Spyre Therapeutics, Inc. (SYRE)

CIK 1636282 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Spyre Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 3, 20268-K0001636282-26-000132
Nov 3, 202610-Q0001636282-26-000131
Oct 9, 2026SCHEDULE 13D/A0001104659-26-115087
Oct 7, 20268-K0001628280-26-065291
Oct 6, 2026424B50001628280-26-065249
Oct 5, 2026424B50001628280-26-064924
Oct 2, 202640001636282-26-000118
Oct 2, 202640001636282-26-000119
Oct 2, 202640001636282-26-000117
Oct 1, 20261440001950047-26-009971
Oct 1, 2026SCHEDULE 13G0001104659-26-112828
Oct 1, 20261440001950047-26-009978
Sep 30, 20261440001950047-26-009876
Sep 8, 20268-K0001636282-26-000113
Sep 3, 202640001636282-26-000111
Sep 3, 202640001636282-26-000109
Sep 3, 202640001636282-26-000107
Sep 1, 20261440001950047-26-008970
Aug 25, 20268-K0001636282-26-000105
Aug 14, 2026SCHEDULE 13G/A0001493215-26-000157
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352655
Aug 10, 202640001636282-26-000102
Aug 7, 20261440001950047-26-007819
Aug 7, 20261440001950047-26-007821
Aug 5, 202640001636282-26-000099